Perimeter Medical Imaging names Aaron Davidson to its board

Perimeter Medical Imaging (TSXV:PINK) appointed Aaron Davidson, currently CFO and SVP of corporate development at Profound Medical (TSX-V:PRN; OTCQX:PRFMF), to its board of directors.

“[Mr. Davidson’s] experience at Profound Medical and extensive knowledge of the medtech landscape is directly relevant to Perimeter, which anticipates a number of near-term clinical development and commercialization catalysts,” Perimeter’s chairman, Dr. Anthony Holler, said in a statement.

“In addition, Mr. Davidson’s work as a partner at H.I.G. BioHealth Partners resulted in numerous success stories in the life sciences sector, and I know Perimeter will benefit from his strategic counsel,” he added.

Mr. Davidson began his career with Eli Lilly and Company (NYSE:LLY), where he spent a decade in various operating management roles. At H.I.G., he led investments in, and represented H.I.G. as a board member of several companies, including Alder Biopharmaceuticals (NASDAQ:ALDR), Forsight Vision5, Gemin X Pharmaceuticals, HyperBranch Medical Technology, Intact Vascular, OnTarget Laboratories, Novadaq Technologies, and Salmedix.

Mr. Davidson commented: “This is an exciting time to join Perimeter’s board of directors; with clinical studies underway to support the development of its ImgAssist AI software and commercialization plans for its innovative medical imaging system, I look forward to contributing to Perimeter’s growth and commercial success.”

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.